ACTRN12613001351707已完成2 期
A multicenter, blinded, placebo-controlled study to investigate the effects of everolimus and/or BEZ235 on the immune response to vaccination in the elderly.
ovartis Institutes for BioMedical Research0 个研究点目标入组 240 人开始时间: 2013年12月10日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 65 Years 至 o limit（—）
- 性别
- All
入选标准
- •Informed Consent obtained
- •>= 65 yo, male and female
排除标准
- •Subjects with underlying unstable medical conditions.
研究者
相似试验
进行中（未招募）
不适用
Multicenter, double-blind placebo controlled study of levetiracetam in the treatment of childhood and juvenile absence epilepsy.therapy of absence epilepsyMedDRA version: 6.1Level: PTClassification code 10015037EUCTR2005-003520-18-ITISTITUTO C. MONDINO60
已完成
不适用
A multicentre randomised double-blind, double-dummy placebo-controlled study to assess the efficacy, safety and cost utility of Probiotic prophylaxis of spinal cord injury Urinary Tract Infection. A Therapeutic Trial. (ProSCIUTTU)People with spinal cord injury suffering from recurrent urinary tract infection resulting from multi-resistant organisms.People with stable multiple sclerosis or cerebral vascular disease, with documented neurogenic bladder on video urodynamic assessment, who also suffer from recurrent urinary tract infection resulting from multi-resitant organisms.Renal and Urogenital - Other renal and urogenital disordersInfection - Studies of infection and infectious agentsNeurological - Other neurological disordersACTRN12610000512022Dr Bon San Bonne Lee207
尚未招募
不适用
Ayurvedic Rasayana therapiesCTRI/2020/07/026700Ayurved Rasayani
尚未招募
4 期
A multicenter, randomized, double-blind study on the efficacy and safety of Gongxuening capsules in reducing postoperative bleeding after induced abortiopostoperative bleeding after induced abortionITMCTR2200005956Peking Union Medical College Hospital
进行中（未招募）
不适用
A multi-center, placebo-controlled study to evaluate the safety of GSK716155 and its effects on myocardial metabolism, myocardial function, and exercise capacity in patients with NYHA Class II/III congestive heart failure.YHA Class II/III congestive heart failure.MedDRA version: 12.1Level: LLTClassification code 10010684Term: Congestive heart failureEUCTR2010-020352-59-GBGlaxoSmithKline Research & Development Limited120